On 1 May, the US National Institutes of Health (NIH), the largest public funder of biomedical research worldwide, announced a new policy that prohibits all foreign sub-awards. This decision is expected to impact South African clinical studies significantly, as billions of rands in research grants are unlikely to be renewed over the coming year. Reports from GroundUp and Spotlight highlight the potential consequences of this policy change for ongoing and future biomedical research in South Africa.
Full Article
